Merck’s WINREVAIR shows promise in phase 2 study for hard-to-treat pulmonary hypertension
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
Exemplifies commitment of Merck to energy efficiency and sustainable practices in high-performance computing by featuring advanced water-cooling systems and a hybrid cloud infrastructure
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
India presents one of the world’s largest untapped opportunities for neurovascular screening
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Subscribe To Our Newsletter & Stay Updated